Abstract:OBJECTIVE:To construct a prokaryotic vector of ZCH-7-2F9 single chain antibody (ScFv2F9) and to obtain the ScFv2F9 protein with biological activity for further studies.METHODS:Primers were synthesized according to the gene sequence of ScFv2F9, four tandem glycin and one serine (G4S) 3linker and multiple cloning site(MCS) of pIVEX2.3-MCS vector, which included NdeI and SmaI enzyme cleaving sites. ScFv2F9 gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Then the gene was cloned to pGEM-T easy and pIVEX2.3-MCS vectors. Positive recombinants (pIVEX2.3-MCS/ScFv2F9) were identified through enzyme cleaving and sequenced before expression. The recombinant plasmids were transfected into E.coli BL21star(DE3)plysS for expression. After purification with Ni+resin and renaturation in vitro, the relative molecular mass (Mr) and the binding activity of the interesting protein were determined by SDS-PAGE and flow cytometry (FCM), respectively.RESULT:The cloned ScFv2F9 gene was identified to be functional by sequencing and expressing. The interesting protein was detected in inclusion body with a Mr of 31 000. The blocking test showed that the positive cell percentage, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 11.73%, 11.96% and 31.57%, respectively after once blockage by scFv2F9 protein, and 26.44 %, 21.75 % and 42.11 % after blockage twice.CONCLUSION:The ScFv2F9 against human CD14 antigen has been successfully expressed in prokaryotic cells with partial biological activity, which lays the foundation for further studies on its immunotoxin and other kinds of engineered antibodies.

Construction and sequencing of the eukaryotic expression vectorof human decay accelerating factor, membrane cofactor protein and CD59

Construction the Eukaryotic Expression Vector of Human Decay Accelerating Factor and Transfection NIH/3T3 Cells

Construction Eukaryotic Expression Vector of Human CD59 and Transfection NIH3T3 Cells by Chitosan Encapsulate

Establishment of a eukaryotic expressing system for human decay accelerating factor

Construction of the Eukaryotic Expression Vector of Human Membrane Cofactor Protein and Transfection NIH 3T3 Cells with Chitosan Nanoparticles

Co-expression and Synergic Effect of Human Complement Regulatory Proteins DAF and MCP

Construction and Identification of Eukaryotic Expressed Plasmid Vector Plenti6/v5- DEST-Cx43 in Human

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Construction and Identification of Eukaryotic Expression Vector of Dact2

Construction of a Eukaryotic Expression Vector Hvegf_(165)-Fused Hirudin/pcdna3.0 and Its Expression

Co-Expression of the Complement Regulatory Proteins Human Daf and Cd59 with an Ires-Mediated Dicistronic Mammalian Vector Enhances Their Cell Protective Effects

[Eukaryotic Expression and Identification of the Recombination Protein of Rat Decay-Accelerating Factor with Pichia Pastoris Expression System].

Vector Construction And Eukaryotic Expression Of The Human Dc-Sign

Construction and Eukaryotic Expression of ADAM9 Gene

Construction, expression, and characterization of AG11-843 and AG11-1581.

Construction and Identification of a Recombinant Baculovirus Transfer Vector of Conserved Dopamine Neurotrophic Factor

Construction and identification of eukaryotic expression vector of tissue factor pathway inhibitor-2 gene

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2

[Construction and Expression of Eukaryotic Expression Vectors of Full-Length, Amino-Terminus and Carboxyl-Terminus Raf Gene.].

Co-expression of Human Complement Regulatory Proteins DAF and MCP with an IRES-mediated Dicistronic Mammalian Vector Enhances Their Cell Protective Effects.